Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis

Clinical trial NCT06779136 · RECRUITING

Trial details

NCT number: NCT06779136
Sponsor: Shanghai Mabgeek Biotech.Co.Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Prurigo Nodularis

Start date: 2025-02-26
Primary completion: 2026-08-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.